Cargando…

Evaluating decontamination protocols for the isolation of Mycobacterium ulcerans from swabs

BACKGROUND: Mycobacterium ulcerans (M. ulcerans) is the causative agent of Buruli Ulcer (BU) disease. In order to inhibit the growth of the microbial contaminants during culture of M. ulcerans, it is necessary to decontaminate BU samples with effective chemical agents. This study aimed at investigat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Owusu, Enid, Newman, Mercy J., Akumwena, Amos, Bannerman, Elizabeth, Pluschke, Gerd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217313/ https://www.ncbi.nlm.nih.gov/pubmed/28056807 http://dx.doi.org/10.1186/s12866-016-0918-x

Ejemplares similares

Susceptibility Profiles of Mycobacterium ulcerans Isolates to Streptomycin and Rifampicin in Two Districts of the Eastern Region of Ghana
por: Owusu, Enid, et al.
Publicado: (2016)

In Vitro Susceptibility of Mycobacterium ulcerans Isolates to Selected Antimicrobials
por: Owusu, Enid, et al.
Publicado: (2017)

Efficacy of an Acid-Oxidizing Solution against Mycobacterium ulcerans
por: Warryn, Louisa, et al.
Publicado: (2022)

Differential Gene Repertoire in Mycobacterium ulcerans Identifies Candidate Genes for Patho-Adaptation
por: Käser, Michael, et al.
Publicado: (2008)

Ongoing Genome Reduction in Mycobacterium ulcerans
por: Rondini, Simona, et al.
Publicado: (2007)

Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates
por: Bénard, Angèle, et al.
Publicado: (2016)

Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease
por: Bolz, Miriam, et al.
Publicado: (2015)

Genomic Diversity and Evolution of Mycobacterium ulcerans Revealed by Next-Generation Sequencing
por: Qi, Weihong, et al.
Publicado: (2009)

Buruli ulcer: The Efficacy of Innate Immune Defense May Be a Key Determinant for the Outcome of Infection With Mycobacterium ulcerans
por: Röltgen, Katharina, et al.
Publicado: (2020)

Microscopic Observation Drug Susceptibility (MODS) Assay: A Convenient Method for Determining Antibiogram of Clinical Isolates of Mycobacterium tuberculosis in Ghana
por: Owusu, Enid, et al.
Publicado: (2020)

Serological Evaluation of Mycobacterium ulcerans Antigens Identified by Comparative Genomics
por: Pidot, Sacha J., et al.
Publicado: (2010)

Structure-Activity Relationship Studies on the Macrolide Exotoxin Mycolactone of Mycobacterium ulcerans
por: Scherr, Nicole, et al.
Publicado: (2013)

On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer
por: Doig, Kenneth D, et al.
Publicado: (2012)

Evolution of two distinct phylogenetic lineages of the emerging human pathogen Mycobacterium ulcerans
por: Käser, Michael, et al.
Publicado: (2007)

Development of a Temperature-Switch PCR-Based SNP Typing Method for Mycobacterium ulcerans
por: Röltgen, Katharina, et al.
Publicado: (2012)

Mycobacterium ulcerans DNA in Bandicoot Excreta in Buruli Ulcer–Endemic Area, Northern Queensland, Australia
por: Röltgen, Katharina, et al.
Publicado: (2017)

A Sero-epidemiological Approach to Explore Transmission of Mycobacterium ulcerans
por: Ampah, Kobina Assan, et al.
Publicado: (2016)

Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans
por: Warryn, Louisa, et al.
Publicado: (2020)

Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice
por: Bieri, Raphael, et al.
Publicado: (2016)

The cell surface protein MUL_3720 confers binding of the skin pathogen Mycobacterium ulcerans to sulfated glycans and keratin
por: Day, Christopher J., et al.
Publicado: (2021)

Sero-Epidemiology as a Tool to Screen Populations for Exposure to Mycobacterium ulcerans
por: Yeboah-Manu, Dorothy, et al.
Publicado: (2012)

Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model
por: Bolz, Miriam, et al.
Publicado: (2016)

Experimental Infection of the Pig with Mycobacterium ulcerans: A Novel Model for Studying the Pathogenesis of Buruli Ulcer Disease
por: Bolz, Miriam, et al.
Publicado: (2014)

Introduction of Mycobacterium ulcerans disease in the Bankim Health District of Cameroon follows damming of the Mapé River
por: Vandelannoote, Koen, et al.
Publicado: (2020)

Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis
por: Ruf, Marie-Thérèse, et al.
Publicado: (2016)

Screening anti-infectious molecules against Mycobacterium ulcerans: A step towards decontaminating environmental specimens
por: Hammoudi, Nassim, et al.
Publicado: (2020)

Antibody-Mediated Neutralization of the Exotoxin Mycolactone, the Main Virulence Factor Produced by Mycobacterium ulcerans
por: Dangy, Jean-Pierre, et al.
Publicado: (2016)

Susceptibility to Mycobacterium ulcerans Disease (Buruli ulcer) Is Associated with IFNG and iNOS Gene Polymorphisms
por: Bibert, Stéphanie, et al.
Publicado: (2017)

Mycobacterium ulcerans Persistence at a Village Water Source of Buruli Ulcer Patients
por: Bratschi, Martin W., et al.
Publicado: (2014)

The immunology of other mycobacteria: M. ulcerans, M. leprae
por: Röltgen, Katharina, et al.
Publicado: (2020)

Improved Protective Efficacy of a Species-Specific DNA Vaccine Encoding Mycolyl-Transferase Ag85A from Mycobacterium ulcerans by Homologous Protein Boosting
por: Tanghe, Audrey, et al.
Publicado: (2008)

Heterogeneity among Mycobacterium ulcerans Isolates from Africa
por: Stragier, Pieter, et al.
Publicado: (2006)

Spatiotemporal Co-existence of Two Mycobacterium ulcerans Clonal Complexes in the Offin River Valley of Ghana
por: Lamelas, Araceli, et al.
Publicado: (2016)

Antimicrobial Activity of Selected Medicinal Plants from a Sub-Saharan African Country against Bacterial Pathogens from Post-Operative Wound Infections
por: Owusu, Enid, et al.
Publicado: (2021)

Primary cultivation: factors affecting contamination and Mycobacterium ulcerans growth after long turnover time of clinical specimens
por: Bratschi, Martin W, et al.
Publicado: (2014)

Mycobacterium ulcerans Disease, Peru
por: Guerra, Humberto, et al.
Publicado: (2008)

Locally Confined Clonal Complexes of Mycobacterium ulcerans in Two Buruli Ulcer Endemic Regions of Cameroon
por: Bolz, Miriam, et al.
Publicado: (2015)

Targeting the Mycobacterium ulcerans cytochrome bc(1):aa(3) for the treatment of Buruli ulcer
por: Scherr, Nicole, et al.
Publicado: (2018)

Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer
por: Bolz, Miriam, et al.
Publicado: (2016)

Identification of the Mycobacterium ulcerans Protein MUL_3720 as a Promising Target for the Development of a Diagnostic Test for Buruli Ulcer
por: Dreyer, Anita, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4981cqmmr8gn54ffrtova2cjml